Algernon Announces Enrollment of First Patient in 2b/3 Human Study of Ifenprodil for Treatment of COVID-19

VANCOUVER, British Columbia, Aug. 05, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it has enrolled its first patient in its multinational Phase 2b/3 human study of NP-120 (Ifenprodil) for the treatment of COVID-19. The countries […]

Read More

REMINDER/Media Advisory: Bombardier to Report its Second Quarter 2020 Financial Results on August 6, 2020

MONTREAL, Aug. 05, 2020 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) will publish its financial results for the second quarter ended June 30, 2020 on August 6, 2020. On August 6, 2020 at 8:00 a.m., EDT, Éric Martel, President and Chief Executive Officer; John Di Bert, Senior Vice President and Chief Financial Officer; and Patrick Ghoche, […]

Read More

Crocus Technology Introduces its 2nd Generation XtremeSense™ TMR 2D Angular Sensor

The CT310, a robust TMR 2D sensor, is targeted for applications that demand contactless, high accuracy angular position detection SANTA CLARA, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) — Crocus Technology Inc., a leading supplier of disruptive XtremeSense™ Tunnel Magneto-Resistance (TMR) sensors, today announces the CT310 sensor, a two-dimensional (2D) angular sensor capable of high-resolution measurements […]

Read More